2334 Nab Paclitaxel (Nab-P) and Gemcitabine (G) as first line chemotherapy (CT) in advanced pancreatic cancer (APDAC) patients (pts): An Italian "real life" study. (September 2015) - Giordano, G.; Febbraro, A.; Vaccaro, V.; Zagonel, V.; De Giorgi, U.; Melisi, D.; Vasile, E.; Bianco, R.; Lo Re, G.; Valente, M.; Formica, V.; Montesarchio, V.; et al.